High risk of heterosexual transmission of human T-cell lymphotropic virus type 1 infection in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
SMID, Jerusa
HAZIOT, Michel E. J.
OLIVEIRA, Augusto C. Penalva de
Citação
JOURNAL OF MEDICAL VIROLOGY, v.89, n.7, p.1287-1294, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Human T-cell lymphotropic virus type 1 is transmitted primarily either through sexual intercourse or from mother to child. The current study investigated sexual transmission and compared the HTLV-1 proviral load between seroconcordant and serodiscordant couples by examining both men and women among the index partners without using subjective criteria to establish the direction of sexual transmission. Between January 2013 and May 2015, 178 HTLV-1-positive patients had spouses, 107 of which had tested partners, thus increasing the initial sample size (46 men and 61 women). Individuals co-infected with HTLV-2 or human immunodeficiency virus were not included in the analysis. From among the included participants, 26 men and 26 women were paired with each other, resulting in 26 seroconcordant couples; 12 seroconcordant couples were formed from another four men and eight women. Forty-three serodiscordant couples were formed from 16 men and 27 women. The rate of seroconcordance was 46.9%. The HTLV-1 proviral load was compared between 19 and 37 seroconcordant and serodiscondant couples, respectively, and the concordant couples showed higher proviral loads (P = 0.03). There were no differences between the groups according to age, relationship length, having a mother or sibling with HTLV-1, race, ethnicity, nationality, education, history of blood transfusion, HAM/TSP, ALT, or hepatitis C virus status. In multivariate analysis, relationship time was shown associated with ocurrence of seroconcordance status. The apparent association between high circulating levels of provirus and seroconcordance rate among couples suggests that proviral loads contribute markedly to the risk of sexual transmission, regardless of gender index.
Palavras-chave
Brazil, HTLV-1, proviral load, sexual transmission
Referências
  1. Biggar RJ, 2006, J INFECT DIS, V193, P277, DOI 10.1086/498910
  2. [Departamento de Estatistica IBGE Brasil], 2015, IBGE CENS DEM 2010
  3. Carneiro-Proietti ABF, 2012, AIDS RES HUM RETROV, V28, P1265, DOI 10.1089/aid.2011.0143
  4. Casseb J, 2008, J MED VIROL, V80, P392, DOI 10.1002/jmv.21111
  5. Catalan-Soares B, 2004, REV PANAM SALUD PUBL, V16, P387, DOI 10.1590/S1020-49892004001200004
  6. Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027
  7. Catalan-Soares BC, 2001, REV BRAS EPIDEMIOL, V4, P81, DOI 10.1590/S1415-790X2001000200003
  8. CHEN YMA, 1991, P NATL ACAD SCI USA, V88, P1182, DOI 10.1073/pnas.88.4.1182
  9. da Costa CA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002272
  10. Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
  11. Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
  12. Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
  13. Hisada M, 2002, CLIN INFECT DIS, V34, P1551, DOI 10.1086/340537
  14. Iga M, 2002, J INFECT DIS, V185, P691, DOI 10.1086/339002
  15. Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115
  16. ISHAK R, 1995, AIDS RES HUM RETROV, V11, P813, DOI 10.1089/aid.1995.11.813
  17. IWAHARA Y, 1990, INT J CANCER, V45, P980, DOI 10.1002/ijc.2910450534
  18. KAJIYAMA W, 1986, J INFECT DIS, V154, P851
  19. Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193
  20. Lairmore MD, 2011, VIRUSES-BASEL, V3, P1131, DOI 10.3390/v3071131
  21. Machuca A, 2001, VIRUS RES, V78, P93, DOI 10.1016/S0168-1702(01)00287-8
  22. Machuca A, 2000, J ACQ IMMUN DEF SYND, V24, P189
  23. Montanheito PA, 2005, BRAZ J MED BIOL RES, V38, P1643, DOI 10.1590/S0100-879X2005001100011
  24. Paiva A, 2014, REV SOC BRAS MED TRO, V47, P265, DOI 10.1590/0037-8682-0232-2013
  25. Percher F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020040
  26. Pique C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00378
  27. Roucoux DF, 2005, J INFECT DIS, V191, P1490, DOI 10.1086/429410
  28. Shioiri S, 1998, INT J CANCER, V75, P15
  29. STUVER SO, 1993, J INFECT DIS, V167, P57
  30. SULLIVAN MT, 1993, TRANSFUSION, V33, P585, DOI 10.1046/j.1537-2995.1993.33793325055.x